Author: Dr. Russell Robbins

Blog

Although biologics and biosimilar drugs only represent 2% of U.S. prescription volume, these naturally sourced medications have recently become the focus of much discussion across healthcare channels. Biologics – often considered specialty drugs – have accounted for as much as 37% of drug spending in a single year.

Blog

While only half as many are diagnosed, researchers estimate that hypothyroidism affects as much as 10% of the general population. Also known as “underactive thyroid,” this condition is characterized by a thyroid gland that doesn’t produce enough thyroid hormone (TH).

Blog

As organizations in life sciences continue to grow and evolve, the strategies they use to reach healthcare providers (HCPs) and patients are following suit. Doctors and patients are inundated with more and more information across digital and traditional channels about relevant diseases, gold-standard treatments, and their various benefits.

Ebooks

Real-world data (RWD) is everywhere. In fact, your company likely already has access to a plethora of RWD. How are you using it to enhance your oncology clinical trial planning – and drive more positive patient outcomes?

Ebooks

For agencies running digital campaigns for your pharmaceutical clients: More data
isn’t always better.

Blog

To create a market assessment, more and more brand strategists are moving towards the use of RWD and RWE. In this blog, we walk through a hypothetical example – sizing the market for Hemophilia A – doing just that.  Creating a market assessment is a critical step in commercializing a new drug. This is because…

Blog

Developing, testing and getting approval for a new drug is a tough feat – but only half the battle. Now that your new drug is ready to be commercialized, you have to get it to the right patients, which starts with finding the right physicians. Here’s how this process works – and how to use…

Blog

On December 1st each year the world unites to commemorate World AIDS Day to support those living with HIV and honor the memory of those who died from AIDS-related illnesses. This year’s theme is “Equalize” to inform people globally of inequalities as one of the growing challenges. Enormous progress has been made in the treatment,…

Blog

Today, the number of Americans aged 65 and older living with Alzheimer’s dementia is estimated at 6.2 million. Without medical breakthroughs to slow or cure the disease, it is projected to approach 13.8 million by 2060. Alzheimer’s is the fifth-leading cause of death among Americans aged 65 and older and in the past twenty years,…